XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance, Common Stock (in shares) at Jun. 30, 2021   269,358,104      
Beginning balance at Jun. 30, 2021 $ 2,575,527 $ 3 $ 3,467,236 $ (898,485) $ 6,773
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   7,403,503      
Issuance of common stock upon exercise of stock options 37,470   37,470    
Issuance of common stock in acquisition (in shares)   183,733      
Issuance of common stock in acquisition 10,000   10,000    
Repurchases of common stock (in shares)   (821)      
Repurchases of common stock (4)   (4)    
Vesting of restricted stock units (in shares)   772,653      
Stock-based compensation 104,879   104,879    
Tax withholding on stock-based compensation (39,817)   (39,817)    
Foreign currency translation adjustments (3,802)       (3,802)
Unrealized loss on securities available for sale (279)       (279)
Net Loss (306,615)     (306,615)  
Ending balance, Common Stock (in shares) at Sep. 30, 2021   277,717,172      
Ending balance at Sep. 30, 2021 2,377,359 $ 3 3,579,764 (1,205,100) 2,692
Beginning balance, Common Stock (in shares) at Jun. 30, 2021   269,358,104      
Beginning balance at Jun. 30, 2021 2,575,527 $ 3 3,467,236 (898,485) 6,773
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustments 3,945        
Net Loss (521,021)        
Ending balance, Common Stock (in shares) at Mar. 31, 2022   285,778,325      
Ending balance at Mar. 31, 2022 2,576,055 $ 3 3,987,881 (1,419,506) 7,677
Beginning balance, Common Stock (in shares) at Sep. 30, 2021   277,717,172      
Beginning balance at Sep. 30, 2021 2,377,359 $ 3 3,579,764 (1,205,100) 2,692
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   4,689,973      
Issuance of common stock upon exercise of stock options 21,674   21,674    
Vesting of restricted stock units (in shares)   803,263      
Vesting of warrants for common stock 198,383   198,383    
Stock-based compensation 101,920   101,920    
Tax withholding on stock-based compensation (72,963)   (72,963)    
Foreign currency translation adjustments 2,341       2,341
Unrealized loss on securities available for sale (657)       (657)
Net Loss (159,735)     (159,735)  
Ending balance, Common Stock (in shares) at Dec. 31, 2021   283,210,408      
Ending balance at Dec. 31, 2021 2,468,322 $ 3 3,828,778 (1,364,835) 4,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   1,258,865      
Issuance of common stock upon exercise of stock options 8,171   8,171    
Repurchases of common stock (in shares)   (9,472)      
Repurchases of common stock (80)   (80)    
Vesting of restricted stock units (in shares)   1,318,524      
Vesting of warrants for common stock 92,169   92,169    
Stock-based compensation 113,005   113,005    
Tax withholding on stock-based compensation (54,162)   (54,162)    
Foreign currency translation adjustments 5,406       5,406
Unrealized loss on securities available for sale (2,105)       (2,105)
Net Loss (54,671)     (54,671)  
Ending balance, Common Stock (in shares) at Mar. 31, 2022   285,778,325      
Ending balance at Mar. 31, 2022 2,576,055 $ 3 3,987,881 (1,419,506) 7,677
Beginning balance, Common Stock (in shares) at Jun. 30, 2022   287,365,373      
Beginning balance at Jun. 30, 2022 2,618,255 $ 3 4,231,303 (1,605,902) (7,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   215,949      
Issuance of common stock upon exercise of stock options 1,192   1,192    
Forfeiture of common stock related to acquisitions (in shares)   (243,384)      
Repurchases of common stock (in shares)   (12,437)      
Repurchases of common stock (109)   (109)    
Vesting of restricted stock units (in shares)   2,166,715      
Vesting of warrants for common stock 108,742   108,742    
Stock-based compensation 141,012   141,012    
Tax withholding on stock-based compensation (27,311)   (27,311)    
Foreign currency translation adjustments (21,546)       (21,546)
Unrealized loss on securities available for sale (5,528)       (5,528)
Net Loss (251,269)     (251,269)  
Ending balance, Common Stock (in shares) at Sep. 30, 2022   289,492,216      
Ending balance at Sep. 30, 2022 2,563,438 $ 3 4,454,829 (1,857,171) (34,223)
Beginning balance, Common Stock (in shares) at Jun. 30, 2022   287,365,373      
Beginning balance at Jun. 30, 2022 $ 2,618,255 $ 3 4,231,303 (1,605,902) (7,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares) 726,425        
Foreign currency translation adjustments $ (16,993)        
Net Loss (779,383)        
Ending balance, Common Stock (in shares) at Mar. 31, 2023   294,650,588      
Ending balance at Mar. 31, 2023 2,511,136 $ 3 4,918,756 (2,385,285) (22,338)
Beginning balance, Common Stock (in shares) at Sep. 30, 2022   289,492,216      
Beginning balance at Sep. 30, 2022 2,563,438 $ 3 4,454,829 (1,857,171) (34,223)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   300,903      
Issuance of common stock upon exercise of stock options 1,372   1,372    
Issuance of common stock, employee share purchase plan (in shares)   500,443      
Issuance of common stock, employee share purchase plan 5,921   5,921    
Vesting of restricted stock units (in shares)   1,798,218      
Vesting of warrants for common stock 128,054   128,054    
Stock-based compensation 144,218   144,218    
Tax withholding on stock-based compensation (18,009)   (18,009)    
Foreign currency translation adjustments 4,522       4,522
Unrealized loss on securities available for sale 3,069       3,069
Net Loss (322,437)     (322,437)  
Ending balance, Common Stock (in shares) at Dec. 31, 2022   292,091,780      
Ending balance at Dec. 31, 2022 2,510,148 $ 3 4,716,385 (2,179,608) (26,632)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock option (in shares)   185,225      
Issuance of common stock upon exercise of stock options 716   716    
Vesting of restricted stock units (in shares)   2,373,583      
Vesting of warrants for common stock 93,922   93,922    
Stock-based compensation 125,902   125,902    
Tax withholding on stock-based compensation (18,169)   (18,169)    
Foreign currency translation adjustments 31       31
Unrealized loss on securities available for sale 4,520       4,520
Unrealized gain (loss) on cash flow hedges (257)       (257)
Net Loss (205,677)     (205,677)  
Ending balance, Common Stock (in shares) at Mar. 31, 2023   294,650,588      
Ending balance at Mar. 31, 2023 $ 2,511,136 $ 3 $ 4,918,756 $ (2,385,285) $ (22,338)